Methimazole can cause a low white blood cell count, although this serious side effect is uncommon. In rare cases, it can sharply reduce neutrophils, the cells that help fight infection. Hyperthyroidism itself can also lower neutrophils, so a low result does not automatically mean the medicine is responsible. Fever or a severe sore throat while taking methimazole needs urgent medical assessment and a blood count.
Methimazole is used to treat an overactive thyroid by reducing the production of thyroid hormones. Most people do not develop a dangerous blood-related reaction, but recognizing the warning signs is important because a sudden reduction in infection-fighting cells can have serious consequences.
How can methimazole lower white blood cells?
White blood cells help the body defend itself against infections. Methimazole can sometimes affect the body's production of these cells, leading to a lower-than-expected white blood cell count, a condition called leukopenia. The medication can also cause a particularly serious reduction in neutrophils, a type of white blood cell that is important for fighting bacterial and fungal infections.
The most concerning reaction is called agranulocytosis, in which neutrophil levels fall dramatically. The U.S. National Library of Medicine's DailyMed prescribing information identifies agranulocytosis as a potentially life-threatening adverse effect of methimazole. Other blood-related problems, including reduced platelets and aplastic anemia, have also been reported.
These reactions are uncommon, but they matter because the body may have more difficulty controlling infections when important white blood cells are greatly reduced. A low result should therefore be interpreted in the context of the medication history, symptoms, and other blood test findings.
Can hyperthyroidism itself cause a low white blood cell count?
Yes. An important distinction is that an overactive thyroid can also contribute to a lower neutrophil count, even before treatment begins. This means a low result does not automatically establish that methimazole caused the change.
The American Thyroid Association describes how high thyroid hormone levels can be associated with reduced neutrophils in people with untreated hyperthyroidism. In many cases, these counts improve as the thyroid condition is brought under control.
Other explanations for a low white blood cell count may include infections, other medications, immune-related conditions, and disorders affecting blood cell production. Healthcare professionals consider previous blood counts, the timing of the change, thyroid test results, symptoms, and other medical conditions to help identify the most likely explanation.
What symptoms could suggest a serious blood-related reaction?
A substantial reduction in neutrophils can make it harder to fight infection. Some people may initially have few noticeable symptoms, while others develop signs of infection or feel generally unwell. These symptoms are not specific to methimazole-related problems, but they need particular attention when they occur during treatment.
- Fever or an unusually high temperature.
- A severe or persistent sore throat.
- Chills or flu-like symptoms.
- A new feeling of being significantly unwell or unusually weak.
- A headache occurring alongside other signs of illness.
MedlinePlus, a service of the U.S. National Library of Medicine, lists fever, sore throat, headache, and chills among the symptoms that require immediate medical attention in someone taking methimazole.
If you develop a fever or severe sore throat while taking methimazole, seek urgent medical care and do not take another dose until a healthcare professional has cleared you to restart it. The American Thyroid Association's hyperthyroidism guidance recommends immediate medical assessment, including a complete blood count, for these warning signs. Do not wait for a routine appointment or a previously scheduled blood test.
What should you do if a blood test shows low white blood cells?
If a blood test reveals a lower-than-expected white blood cell count while you are taking methimazole but you have no warning symptoms, contact the prescribing clinician promptly for instructions. Do not independently change or permanently discontinue your medication based on an isolated result. The clinician can determine whether another dose should be taken, whether testing is needed promptly, and whether treatment should be changed.
The first step is often a complete blood count (CBC) with a differential. A CBC measures the number of different blood cells, while the differential identifies the proportions or numbers of individual white blood cell types. The absolute neutrophil count, or ANC, can help clinicians assess how many infection-fighting neutrophils are present.
Depending on the findings, a clinician may review older blood tests, repeat the CBC, examine other medications, or investigate alternative explanations. If a dangerous medication-related reduction is confirmed or strongly suspected, methimazole may need to be stopped under medical supervision, and alternative treatment for the overactive thyroid may be considered.
If the blood count is substantially reduced or there are signs of infection, urgent assessment may be needed. Severe neutropenia can require hospital-based care, depending on the clinical situation. The appropriate response depends on the actual findings and the person's overall condition rather than the total white blood cell count alone.
Does everyone taking methimazole need regular white blood cell tests?
A baseline blood count is important when evaluating newly diagnosed hyperthyroidism. It helps the clinician understand whether white blood cells or neutrophils are already lower than expected before treatment begins. This information can be especially useful when deciding how to manage someone who has an existing blood count abnormality.
However, scheduled blood tests do not reliably predict every serious reaction. The American Thyroid Association's review of white blood cell monitoring during antithyroid treatment explains that agranulocytosis can develop abruptly, which limits the usefulness of routine testing alone for detecting this complication in advance.
Monitoring arrangements can vary according to the patient's medical history, local practice, and the clinician's assessment. Thyroid function tests remain important for adjusting methimazole treatment, but they do not replace a CBC when symptoms raise concern about low white blood cells.
The most useful precaution is to understand the warning signs and know how to obtain prompt medical assessment. If your clinician has given you specific instructions about blood tests or medication interruption, follow those instructions and clarify any uncertainty before continuing treatment.
Can white blood cell counts recover after methimazole is stopped?
Recovery is possible, and blood cell counts often improve after the medication responsible for the reaction is discontinued. The outcome depends on the nature and extent of the blood abnormality, whether an infection or another condition is present, and how the problem is managed.
When agranulocytosis is suspected, treatment decisions should not be delayed while waiting to see whether symptoms improve. A clinician may arrange repeat blood counts, assess for infection, and determine whether additional treatment or observation is required. If methimazole cannot be used safely, alternative approaches to treating hyperthyroidism may be discussed.
Do not restart methimazole after a suspected serious blood reaction unless the treating clinician has specifically advised that it is safe. The decision should account for the blood test findings and the risks of further exposure.